Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving ...

Resalis Therapeutics today announced the dosing of the first participant in a Phase 1b clinical study of its lead candidate, RES-010, a novel antisense oligonucleotide targeting microRNA-22 (miR-22), ...

Brown is the vice president of medical affairs and patient advocacy at Southern Research and project lead for Catalyst. Sodeke is the resident bioethicist and professor of bioethics at the Center for ...

Data support AGAMREE®’s potential use as a treatment across a broad range of chronic inflammatory rare diseases ...

AMR Clinical (AMR), an award-winning multi-site research company, has acquired ClinOhio Research Services (ClinOhio), a multi-therapeutic research site founded in 2017 and based in Columbus, Ohio. The ...

A clinical study that began in a research unit in Gqeberha (PE), Eastern Cape, has transformed global treatment of drug-resistant tuberculosis.

Paradigm Health, the sole technology provider operationalizing the U.S. Food and Drug Administration's (FDA) Real-Time Clinical Trials (RTCT) proof-of-concept studies, has formally submitted its ...

Samsung and Alcedis will explore how Galaxy Watch biometric data can support clinical trials, digital endpoints, and drug ...

Marginalized racial and ethnic groups, women, and other historically disenfranchised populations are substantially underrepresented in clinical trials, despite increasing concern about this issue ...

IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26FDA’s decision follows ...